ACTIVE_NOT_RECRUITING

YES Study - Newly Diagnosed/Metastatic Intervention

Talk to us

Conditions

Breast CancerSymptom, Behavioral

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This research study is being done to monitor common symptoms and behavior, and to provide supportive care information and peer support, as well as research opportunities for young women ages of 18-39 years old who have been diagnosed with stage 0-IV stage breast cancer using a web-based portal (YES), built for smartphones, tablets, and computers.

Official Title

Young, Empowered &Amp; Strong (YES): The Young Women's Breast Cancer Study 2- Focus on Newly Diagnosed/Metastatic Intervention

Quick Facts

Study Start:2020-09-16
Study Completion:2028-03-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT04379414

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 39 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Stage 0-3
  2. * Female
  3. * diagnosed with breast cancer between the ages of 18-39 years
  4. * less than 3 months post diagnosis date of new primary or local recurrence (prior history of other cancer is allowed as long as treated with curative intent and no evidence of disease from that cancer)
  5. * has not started treatment for breast cancer diagnosis yet
  6. * is planning to get care at DFCI
  7. * be fluent in and able to read English
  8. * have internet access on a regular basis at the time of consent that can support the web-based platform
  9. * Stage IV
  10. * Female
  11. * initial diagnosis of breast cancer between the ages of 18-39 years
  12. * be fluent in and able to read English
  13. * have internet access on a regular basis at the time of consent that can support the web-based platform
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Principal Investigator

Ann H Partridge, MD
PRINCIPAL_INVESTIGATOR
Dana-Farber Cancer Institute

Study Locations (Sites)

Dana Farber Cancer Institute
Boston, Massachusetts, 02215
United States

Collaborators and Investigators

Sponsor: Dana-Farber Cancer Institute

  • Ann H Partridge, MD, PRINCIPAL_INVESTIGATOR, Dana-Farber Cancer Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-09-16
Study Completion Date2028-03-01

Study Record Updates

Study Start Date2020-09-16
Study Completion Date2028-03-01

Terms related to this study

Keywords Provided by Researchers

  • Breast Cancer
  • Symptom, Behavioral

Additional Relevant MeSH Terms

  • Breast Cancer
  • Symptom, Behavioral